Catalyst Wire Dossier Catalyst Wire Dossier

Niaspan

niacin (nicotinic acid) · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Niaspan, covering 2006-11-01 to 2026-08-28. Get the full timeline:

Most recent: Clinical Trial Results: Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery [Phase 2]

See pricing